Sophion case stories

With the help of our automated patch clamp solutions, we have asked our customers how they use the technology to shape their future.

Case story: Making a difference through electrophysiology – QPatch Compact offers customized control over experiments


From QPatch to QPatch Compact – NMD Pharma breaks new ground in neuromuscular diseases

NMD Pharma is devoted to discovering and delivering life-transforming therapies for people living with neuromuscular diseases. As a research-based company, they are determined to be in control of their research and quality. Sophion’s automated patch clamp instruments have been a part of NMD Pharma’s research, and all the knowledge generated along the way has been an important part of NMD Pharma’s journey.

"With our existing QPatch we have the possibility for screening more compounds, but the QPatch Compact is enabling us to ask detailed questions"

— Martin Gruwier Broch-Lips, Head of Biological Research, NMD Pharma A/S
Read the full story

Case story: How automated patch clamp technology is playing a key role for B’SYS in delivering high-quality and reliable cell lines


State-of-the-art cell lines and flexible collaboration with experts in biomedical research

As a niche Contract Research Organization focused on ion channel discovery, offering the best service and customer satisfaction is always of the highest priority at B’SYS – and Sophion Bioscience’s automated patch clamp technology is playing a key role in their journey.

"Sophion provides the best solution for us when it comes to system, service, and support. Thanks to a long-term collaboration, the majority of B'SYS cell lines are validated for use across Sophion’s APC platforms"

— Daniel Konrad, CEO at B’SYS GmbH
Read the full story

Case story: QPatch secured the best infrastructure for Linköping University’s new academic core facility


An academic core facility for a Swedish university – how QPatch ensured the best infrastructure

A high-throughput QPatch automated patch clamp instrument from Sophion Bioscience enabled Linköping University to accelerate its research into a new epilepsy drug – and to get the green light to build a national core facility for ion channel research.

"Our partnership with Sophion and access to their expertise made a big impression on our funders. It gave them a hands-on, real-world example of what you can achieve with automated patch clamping and an expert supplier"

— Fredrik Elinder, Professor at Linköping University
Read the full story

Case story: Sophion technology helped Metrion Biosciences meet higher customer demands and growing assay complexity


Automated patch clamping – a silver bullet for higher customer demands and growing assay complexity

Metrion Biosciences successfully met the challenge of  growing complexity in ion channel research by adopting Sophion Bioscience’s QPatch II and Qube 384 automated patch clamp platforms. The move transformed Metrion’s research output, enabling it to take on more – and larger – projects and grow its customer base.

"We have more projects than we would have had in the past and it just means our processes have to be more robust in making sure we execute those projects in a timely manner as possible"

— Gary Clark, Director of Screening Technologies at Metrion Biosciences
Read the full story

Get in Touch

We strive to provide the best for our customers, and we are always ready to help. Please let us know if you have a question for us.

Follow us